The burgeoning field of short-chain protein therapeutics represents a exciting paradigm shift in how we approach disease and optimize bodily performance. Differing from traditional small molecules, peptidic compounds offer remarkable specificity, often focusing on specific receptors or enzymes with unprecedented accuracy. This targeted action lesse